Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | Adagrasib |
Trade Name | Krazati |
Synonyms | MRTX849|MRTX-849|MRTX 849 |
Drug Descriptions |
Krazati (adagrasib) covalently binds to and stabilizes GDP-bound KRAS G12C, thereby preventing KRAS downstream signaling and potentially inhibiting tumor growth (PMID: 31658955). Krazati (adagrasib) is FDA approved for use in patients with locally advanced or metastatic non-small cell lung cancer harboring KRAS G12C who have received one or more prior therapy (FDA.gov). |
DrugClasses | KRAS G12C inhibitor 32 |
CAS Registry Number | 2326521-71-3 |
NCIT ID | C157493 |